DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
7.03
-0.21 (-2.90%)
At close: Sep 8, 2026, 4:00 PM EDT
7.03
0.00 (0.00%)
After-hours: Sep 8, 2026, 4:00 PM EDT
DarioHealth Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 21 | 22.36 | 27.04 | 20.35 | 27.66 | 20.51 | |
Revenue Growth | -22.65% | -17.31% | 32.86% | -26.41% | 34.82% | 170.76% |
Cost of Revenue | 8.07 | 8.02 | 8.75 | 9.98 | 13.64 | 12.44 |
Gross Profit | 12.93 | 14.34 | 18.3 | 10.37 | 14.01 | 8.07 |
Selling, General & Admin | 33.6 | 35.53 | 46.1 | 41.8 | 46.82 | 62.36 |
Research & Development | 10.45 | 13.79 | 24.18 | 20.25 | 19.65 | 17.22 |
Amortization of Goodwill & Intangibles | 0.72 | 1.67 | 5.03 | 4.39 | 4.36 | 2.97 |
Operating Expenses | 44.76 | 50.99 | 75.31 | 66.43 | 70.82 | 82.54 |
Operating Income | -31.83 | -36.66 | -57.02 | -56.06 | -56.81 | -74.47 |
Interest Expense | -5.29 | -3.02 | - | -0.53 | -2.6 | - |
Interest & Investment Income | 0.71 | 0.94 | 1.12 | 1.87 | 0.51 | 0.04 |
Currency Exchange Gain (Loss) | -0.28 | -0.28 | -0 | -0.21 | 0.24 | -0.2 |
Other Non Operating Income (Expenses) | 1.49 | -2.6 | 12.03 | -4.34 | -3.53 | -0.08 |
EBT Excluding Unusual Items | -35.2 | -41.61 | -43.87 | -59.27 | -62.19 | -74.71 |
Merger & Restructuring Charges | - | - | -0.73 | -0.13 | - | -2.02 |
Gain (Loss) on Sale of Investments | - | - | - | 0.04 | - | - |
Pretax Income | -35.2 | -41.61 | -44.6 | -59.36 | -62.19 | -76.73 |
Income Tax Expense | 0.47 | 0.11 | -1.85 | 0.06 | 0 | 0.03 |
Net Income | -35.67 | -41.71 | -42.75 | -59.43 | -62.19 | -76.76 |
Preferred Dividends & Other Adjustments | -28.67 | -1.4 | -12.66 | -4.57 | -2.24 | -9.24 |
Net Income to Common | -7 | -40.31 | -30.09 | -54.86 | -59.96 | -67.52 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 7 | 4 | 2 | 1 | 1 | 1 |
Shares Outstanding (Diluted) | 7 | 4 | 2 | 1 | 1 | 1 |
Shares Change | 171.67% | 62.44% | 72.84% | 20.04% | 42.45% | 178.23% |
EPS (Basic) | -0.95 | -10.12 | -12.27 | -38.67 | -50.74 | -81.39 |
EPS (Diluted) | -0.95 | -10.12 | -12.27 | -38.67 | -50.80 | -81.40 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -25.48 | -26.08 | -38.7 | -30.96 | -48.29 | -50.67 |
Free Cash Flow Per Share | -3.45 | -6.55 | -15.78 | -21.83 | -40.86 | -61.08 |
Gross Margin | 61.57% | 64.11% | 67.66% | 50.95% | 50.67% | 39.34% |
Operating Margin | -151.60% | -163.94% | -210.85% | -275.46% | -205.42% | -363.06% |
Profit Margin | -33.32% | -180.28% | -111.28% | -269.56% | -216.80% | -329.16% |
Free Cash Flow Margin | -121.35% | -116.66% | -143.12% | -152.14% | -174.60% | -247.01% |
EBITDA | -29.71 | -33.52 | -49.59 | -51.08 | -52.09 | -70.02 |
EBITDA Margin | -141.51% | -149.90% | -183.39% | -250.96% | -188.36% | - |
D&A For EBITDA | 2.12 | 3.14 | 7.43 | 4.99 | 4.72 | 4.46 |
EBIT | -31.83 | -36.66 | -57.02 | -56.06 | -56.81 | -74.47 |
EBIT Margin | -151.60% | -163.94% | -210.85% | -275.46% | -205.42% | - |
Revenue as Reported | 21 | 22.36 | 27.04 | 20.35 | 27.66 | 20.51 |